Annual Shareholders Equity
$12.58 M
-$6.30 M-33.38%
December 31, 2023
Summary
- As of March 13, 2025, GANX annual stockholders equity is $12.58 million, with the most recent change of -$6.30 million (-33.38%) on December 31, 2023.
- During the last 3 years, GANX annual shareholders equity has risen by +$6.38 million (+102.81%).
- GANX annual shareholders equity is now -63.87% below its all-time high of $34.82 million, reached on December 31, 2021.
Performance
GANX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$8.91 M
-$2.88 M-24.40%
September 30, 2024
Summary
- As of March 13, 2025, GANX quarterly stockholders equity is $8.91 million, with the most recent change of -$2.88 million (-24.40%) on September 30, 2024.
- Over the past year, GANX quarterly shareholders equity has dropped by -$3.67 million (-29.17%).
- GANX quarterly shareholders equity is now -79.96% below its all-time high of $44.46 million, reached on March 31, 2021.
Performance
GANX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
GANX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -33.4% | -29.2% |
| 3 y3 years | +102.8% | -74.4% |
| 5 y5 years | - | -74.4% |
GANX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.9% | at low | -74.4% | +21.5% |
| 5 y | 5-year | -63.9% | +2895.8% | -80.0% | +43.6% |
| alltime | all time | -63.9% | +2895.8% | -80.0% | +43.6% |
Gain Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $8.91 M(-24.4%) |
| Jun 2024 | - | $11.78 M(+36.4%) |
| Mar 2024 | - | $8.64 M(-31.3%) |
| Dec 2023 | $12.58 M(-33.4%) | $12.58 M(+71.6%) |
| Sep 2023 | - | $7.33 M(-33.9%) |
| Jun 2023 | - | $11.09 M(-26.7%) |
| Mar 2023 | - | $15.14 M(-19.8%) |
| Dec 2022 | $18.88 M | $18.88 M(-16.7%) |
| Sep 2022 | - | $22.66 M(-16.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $27.02 M(-15.1%) |
| Mar 2022 | - | $31.83 M(-8.6%) |
| Dec 2021 | $34.82 M(+461.4%) | - |
| Dec 2021 | - | $34.82 M(-7.3%) |
| Sep 2021 | - | $37.55 M(-9.3%) |
| Jun 2021 | - | $41.39 M(-6.9%) |
| Mar 2021 | - | $44.46 M(+616.9%) |
| Dec 2020 | $6.20 M(-1478.5%) | - |
| Dec 2020 | - | $6.20 M |
| Dec 2019 | -$449.90 K | - |
FAQ
- What is Gain Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Gain Therapeutics?
- What is Gain Therapeutics annual shareholders equity year-on-year change?
- What is Gain Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Gain Therapeutics?
- What is Gain Therapeutics quarterly shareholders equity year-on-year change?
What is Gain Therapeutics annual stockholders equity?
The current annual shareholders equity of GANX is $12.58 M
What is the all time high annual shareholders equity for Gain Therapeutics?
Gain Therapeutics all-time high annual stockholders equity is $34.82 M
What is Gain Therapeutics annual shareholders equity year-on-year change?
Over the past year, GANX annual stockholders equity has changed by -$6.30 M (-33.38%)
What is Gain Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of GANX is $8.91 M
What is the all time high quarterly shareholders equity for Gain Therapeutics?
Gain Therapeutics all-time high quarterly stockholders equity is $44.46 M
What is Gain Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, GANX quarterly stockholders equity has changed by -$3.67 M (-29.17%)